I'll research KO's recent performance, guidance, and market context before writing the preview. Let me start by gathering key documents.Good context. Let me read the most recent earnings materials and the year-ago quarter for comparison.Now let me get the year-ago Q2 2025 release for comparison and recent stock price data, plus sector context.I have enough to write a comprehensive preview. Let me quickly compute a couple of stock performance figures.# The Coca-Cola Company (KO) — Q2 2026 Earnings Preview

Report date: Tuesday, July 28, 2026 (before market open) | Event: 2026 Q2 Earnings Call, 8:30 a.m. ET Recent price: ~$84 | YTD: +21.7% (vs. PEP -1.7%)


The One-Line Setup

Coca-Cola heads into Q2 as one of 2026's staples standouts — the stock is up ~22% YTD and near highs — after a strong Q1 in which management raised full-year EPS guidance. The bar is therefore higher than usual. The two things that will actually move the stock: (1) whether the "balanced algorithm" (volume + price/mix) held up as the calendar tailwind reversed, and (2) any quantification of the Fairlife ransomware attack and its impact on the second-half outlook.


Consensus & What's Expected

Metric Q2 2026 Consensus Q2 2025 Actual Implied Growth
Comparable EPS ~$0.93 $0.87 +6.9%
Net revenue ~$13.2B $12.5B ~+5%
Organic revenue ~+3.5% (Street) +5%

Note the tension between the reported-revenue estimate (+5%) and the organic estimate (~3.5%): the gap reflects an expected currency tailwind (~1%) plus the reversal of Q1's calendar benefit. Management explicitly guided that concentrate shipments would lag unit cases by a couple of points in Q2 — the mirror image of the 6 extra days that flattered Q1's concentrate/organic figures. So investors should mentally separate the optical Q1 strength (+10% organic) from underlying trend, and expect a more subdued Q2 headline.


Reading Q1 for the Q2 Signal

Q1 2026 was genuinely strong but had asterisks: - +3% global unit case volume, growth in all segments, and a 20th consecutive quarter of value-share gains. - +10% organic revenue, but ~5 points came from six extra shipping days; underlying was described as "on track" with the 4–5% full-year guide. - Price/mix was only +2% (4 pts pricing, -2 pts mix), softer than the recent trend, from Easter timing, North America category mix (water), and affordability/geographic mix in Asia and LatAm. - Comparable operating margin +70 bps to 34.5%, but gross margin fell ~30 bps — a first in a few years — on tea/coffee commodity inflation and a one-off juice-inventory phasing item in China (APAC operating income actually fell 17% currency-neutral).

What to watch in Q2: Management framed the year as a "balanced algo" of roughly 3% volume / 2% price-mix that varies quarter to quarter. Given Q2 2025 was a soft volume comp (-1% volume, +6% price/mix), KO should have an easier volume base but a harder price/mix comp. Watch whether the affordability push (entry packs, mini-cans, RGM in developing markets) continues to crimp price/mix — this is the key debate coming out of Q1.


The Wildcard: Fairlife Ransomware

This is the differentiated story into the print. In mid-July, KO disclosed that its ~$4B Fairlife dairy brand suffered a ransomware attack that temporarily suspended U.S. production (Canada unaffected). By July 27 the company said Fairlife had resumed the majority of production across its four U.S. facilities.

Expect this to dominate Q&A. A confident "contained, recovering, no change to guidance" message would be a relief; a quantified drag or guidance caveat would be the negative surprise.


Full-Year Guidance (raised at Q1) — Watch for Changes

The key question: does management raise again, hold, or introduce caution given Fairlife and geopolitics? After a Q1 raise and a 22% YTD run, the market may need a reiteration-plus rather than just a reiteration.


Other Swing Factors & Themes


Bottom Line

KO's model is working — 20 straight quarters of share gains, resilient volume, and FX flipping to a tailwind — and it has clearly separated itself from a struggling PepsiCo, which is partly why the stock has re-rated. That strength is the risk: expectations and valuation are elevated, so a simple "in-line and reiterate" may not be enough to sustain the momentum. The three things to grade the print on:

  1. Underlying quality — did volume and price/mix stay "balanced" once the Q1 calendar benefit reversed (concentrate lagging cases)?
  2. Fairlife — is the disruption contained to Q3/Q4 with no full-year guidance change?
  3. Guidance posture — another raise, or a more cautious tone given geopolitics and Fairlife?

A clean beat with an unchanged-to-raised full-year outlook and a reassuring Fairlife message is the bull case; conservative second-half commentary on Fairlife, EMEA, and commodity costs is the risk into a stock that has already priced in a lot of good news.

Note: consensus figures above are drawn from press previews and may differ modestly from the final Street-compiled numbers; treat organic-growth expectations (~3.5%) and the reported-revenue estimate (~$13.2B) as directional.